Summit Securities Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-181
| Closed | -$1.61K | – | 1149 |
|
|
2025
Q1 | $1.61K | Buy |
+181
| New | +$1.61K | ﹤0.01% | 543 |
|
|
2024
Q1 | – | Sell |
-100
| Closed | -$2K | – | 580 |
|
|
2023
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 421 |
|
|
2013
Q3 | – | Sell |
-400
| Closed | -$11K | – | 394 |
|
|
2013
Q2 | $11K | Buy |
+400
| New | +$11K | 0.01% | 253 |
|